NP and the BOD will have a legacy in place of improving the lives of millions of people. A continuing enterprise that will challenge BP and hopefully release further drugs at a reasonable price would only add to that legacy.

For the shareholders that bought in at a low price we'll have stories about buying into a stock that boomed like nothing else seen before.